Hosted on MSN1mon
PTCL and MTronic set to redefine lifestyles by automating homes with cutting-edge IoT solutionsPTCL’s extensive customer base and robust digital infrastructure, combined with MTronic’s state-of-the-art IoT devices, ranging from smart sensors to automated lighting and thermostats, ensure ...
Pakistan Telecommunication Company Limited (PTCL) has appointed Zarrar Hasham Khan as its new chairman, replacing Azfar ...
KARACHI: The Pakistan Telecommunication Company Limited (PTCL) has announced a new undersea fibre-optic cable, set to come online by 2026. The Africa-1 Submarine Cable will be connected to PTCL ...
Golidocitinib is a JAK1 only inhibitor approved for the treatment of relapsed or refractory PTCL The combination of ...
Syed Atif Raza, Group Chief Commercial Officer, PTCL and Ufone 4G, stated, 'The WhatsApp-based bill payment solution aligns with our digital transformation strategy, aimed at enhancing customer ...
Pakistan Telecommunication Company Limited (PTCL) has continued to face massive losses that amounted to Rs14.39 billion on a consolidated basis for the year ended December 31, 2024. In comparison ...
KARACHI: The Pakistan Telecommunication Company Ltd (PTCL) has successfully landed the Africa-1 submarine internet cable at Karachi. In a statement on Saturday, the telecom company said the ...
Pakistan Telecommunication Company Limited (PTCL) has successfully connected Pakistan to the Africa-1 submarine cable system, marking a significant advancement in the nation's digital infrastructure.
FAISALABAD: PTCL (Ufone) organised its annual Iftar dinner for friends of print and electronic media at local hotel, which ...
Zarrar Hasham Khan has been appointed as chairman of Pakistan Telecommunication Company Limited (PTCL), replacing Azfar Manzoor. The company disclosed the development in its notice to the Pakistan ...
PTCL names Zarrar Hasham Khan as its new chairman, replacing Azfar Manzoor. Learn more about the leadership change here!
Patients relapse or develop resistance to medications and, even in some cancers with approved targeted therapies - such as peripheral T-cell lymphoma (PTCL), which accounts for ~5%–10% of all ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback